Research Topics
| Jochen WohrleSummaryAffiliation: University of Ulm Country: Germany Publications
| Collaborators
|
Detail Information
Publications
Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteriesJochen Wohrle
Department of Internal Medicine II, University of Ulm, Ulm, Germany
Catheter Cardiovasc Interv 81:793-9. 2013..We sought to evaluate the efficacy and safety of paclitaxel-coated balloon plus bare-metal stenting (BMS) in chronic total occlusions (CTOs)...- SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry studyJochen Wohrle
Department of Internal Medicine II Cardiology, University of Ulm, Ulm, Germany
J Am Coll Cardiol 60:1733-8. 2012..This study sought to assess the safety and efficacy of paclitaxel-coated balloon (PCB) angioplasty in an international, multicenter, prospective, large-scale registry study... 
PFO closuRE and CryptogenIc StrokE (PRECISE) registry: a multi-center, international registryJochen Wohrle
Department of Internal Medicine II, Cardiology, University of Ulm, Albert Einstein Allee 23, 89081 Ulm, Germany
Clin Res Cardiol 101:787-93. 2012..The primary objective of the study was to determine the degree of risk for stroke or transient ischemic attack (TIA) in patients after Premere™ PFO closure device implantation...- Drug-coated balloons for coronary and peripheral interventional proceduresJochen Wohrle
Clinic of Internal Medicine II, University of Ulm, Albert Einstein Allee 23, 89081 Ulm, Germany
Curr Cardiol Rep 14:635-41. 2012..Registries indicate PCB to also be effective in lesions below the knee. Since there is no certain class effect, efficacy and safety have to be demonstrated for different types of PCB for coronary and peripheral interventions... - Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the horizons-AMI CMRI substudyJochen Wohrle
Clinic of Internal Medicine II, University of Ulm, Ulm, Germany
Catheter Cardiovasc Interv 79:1083-9. 2012..Whether a possible reduction in infarct size with bivalirudin may have contributed to the enhanced survival with this agent is unknown... - Impact of percutaneous device implantation for closure of patent foramen ovale on valve insufficienciesJochen Wohrle
Department of Internal Medicine II Cardiology, University of Ulm, Albert Einstein Allee 23, Ulm 89081, Germany
Circulation 119:3002-8. 2009..We studied the acute and long-term impact of percutaneous device implantation for PFO closure on valve insufficiencies in cardiac magnetic resonance imaging... - Everolimus-eluting stents for treatment of chronic total coronary occlusionsJochen Wohrle
Department of Internal Medicine II, University of Ulm, Albert Einstein Allee 23, 89081 Ulm, Germany
Clin Res Cardiol 101:23-8. 2012..We sought to determine the antiproliferative impact of the everolimus-eluting Xience V stent in CTOs... - Carbon-coated stents in patients with acute coronary syndromesJochen Wohrle
Department of Internal Medicine II, University of Ulm, Ulm, Germany
Clin Cardiol 32:E1-6. 2009..We evaluated angiographic and clinical results of non-drug-eluting carbon-coated stents... - Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery diseaseJochen Wohrle
Clinic of Internal Medicine II, University of Ulm, Germany
Heart 97:1338-42. 2011..Percutaneous coronary intervention with stent implantation is limited by the occurrence of re-stenosis and the risk of stent thromboses... - Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI Trial)Jochen Wohrle
Clinic of Internal Medicine II, University of Ulm, Germany
Am J Cardiol 106:1218-24. 2010..In conclusion, in the HORIZONS-AMI trial, 30-day and 1-year survival rates and clinical outcomes were comparable in patients with STEMI requiring and not requiring transfer for primary PCI... - Prevalence of myocardial scar in patients with cryptogenic cerebral ischemic events and patent foramen ovaleJochen Wohrle
Clinic of Internal Medicine II, University of Ulm, Ulm, Germany
JACC Cardiovasc Imaging 3:833-9. 2010..This study sought to evaluate the prevalence of subclinical myocardial infarctions with cardiovascular magnetic resonance imaging (CMRI) in patients with patent foramen ovale (PFO) after cryptogenic cerebral ischemic events... - Results of intracoronary stem cell therapy after acute myocardial infarctionJochen Wohrle
University of Ulm, Clinic for Internal Medicine II, Ulm, Germany
Am J Cardiol 105:804-12. 2010.... - Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery diseaseJochen Wohrle
Department of Internal Medicine II, University of Ulm, Ulm, Germany
Clin Res Cardiol 97:726-33. 2008..We studied the hypothesis that pioglitazone improves coronary endothelial dysfunction in non-diabetic patients with coronary artery disease (CAD) in a randomized, placebo-controlled, double-blind trial... - Patients with in-stent restenoses: comparison of intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter with the polymer-based paclitaxel-eluting taxus-express stentJ Wohrle
Department of Internal Medicine II, University of Ulm, Robert Koch Str 8, 89081 Ulm, Germany
Nuklearmedizin 46:185-91. 2007..We compared the intracoronary beta-brachytherapy using a liquid rhenium-188 filled balloon with the slow-release, polymer-based, paclitaxel-eluting Taxus-Express stent for treatment of in-stent restenoses... - [Stent thrombosis in the era of drug-eluting stents]Jochen Wohrle
Klinik fur Innere Medizin II, Universitatsklinikum Ulm, Ulm
Herz 32:411-8. 2007..In complex lesions combined antiplatelet treatment should be prescribed 24 months or longer (e.g., DES after brachytherapy). Patients scheduled for surgical procedures or patients with reduced compliance should not be treated with DES... - Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventionsJ Wohrle
Department of Internal Medicine II, University of Ulm, Germany
Clin Res Cardiol 96:70-6. 2007..Furthermore, a meta-analysis was performed regarding use of drug-eluting (DES) vs bare-metal stents (BMS) in SVG lesions... - Myocardial perfusion reserve in cardiovascular magnetic resonance: Correlation to coronary microvascular dysfunctionJochen Wohrle
Department of Internal Medicine II, University of Ulm, Ulm, Germany
J Cardiovasc Magn Reson 8:781-7. 2006..CMR combined with adenosine could be proposed as a non-invasive tool to evaluate CMD... - Closure of patent foramen ovale after cryptogenic strokeJochen Wohrle
Department of Internal Medicine II, University of Ulm, 89081 Ulm, Germany
Lancet 368:350-2. 2006 - Intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter in restenotic lesions of native coronary arteries and venous bypass graftsJochen Wohrle
Department of Internal Medicine II, University of Ulm, Robert Koch Strasse 8, 89081 Ulm, Germany
Eur J Nucl Med Mol Imaging 33:1314-20. 2006..Against this background, we wanted to assess the impact of intracoronary beta-brachytherapy using a liquid (188)Re-filled balloon in restenotic lesions in native coronary arteries and venous bypass grafts... - Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapyJochen Wohrle
Department of Internal Medicine II, University of Ulm, 89081 Ulm, Germany
Cardiovasc Revasc Med 7:2-6. 2006..We report clinical and angiographic data regarding the safety and efficacy of rhenium-188 brachytherapy in restenoses after brachytherapy failure... 
Angiographic results of the cobalt chromium Vision and Mini-Vision stentsJochen Wohrle
Department of Internal Medicine II, University of Ulm, Ulm, Germany
Can J Cardiol 25:581-4. 2009..In the Basel Stent Kosten Effektivitats Trial (BASKET), target vessel revascularization after six months was nonsignificantly different between DES and BMS with clinical follow-up...- Intracoronary beta-irradiation with a rhenium-188-filled balloon catheter: a randomized trial in patients with de novo and restenotic lesionsMartin Hoher
Department of Internal Medicine II, University of Ulm, Robert Koch Strasse 8, 89081 Ulm, Germany
Circulation 107:3022-7. 2003..Intracoronary irradiation reduces neointimal proliferation. We studied the efficacy of a self-centering liquid rhenium-188-filled balloon catheter for coronary beta-brachytherapy... - Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplastyJochen Wohrle
Internal Medicine II, University of Ulm, Robert Koch Strasse 8, 89081 Ulm, Germany
Circulation 107:1840-3. 2003..We studied whether intracoronary bolus administration of abciximab is associated with a reduced MACE rate compared with the standard intravenous bolus application... - Diagnostic performance of magnetic resonance first pass perfusion imaging is equally potent in female compared to male patients with coronary artery diseaseNico Merkle
Clinic of Internal Medicine II Cardiology, University Hospital of Ulm, Albert Einstein Allee 23, 89081, Ulm, Germany
Clin Res Cardiol 99:21-8. 2010..Therefore, we tested the diagnostic power of cardiac magnetic resonance first pass perfusion imaging (CMR-FPPI) for the diagnosis of significant coronary stenoses in females versus males... - Assessment of myocardial perfusion for detection of coronary artery stenoses by steady-state, free-precession magnetic resonance first-pass imagingNico Merkle
Department of Internal Medicine II, University of Ulm, Robert Koch Strasse 8, 89081 Ulm, Germany
Heart 93:1381-5. 2007..To evaluate the diagnostic impact of magnetic resonance imaging (MRI) first-pass perfusion using steady-state, free-precession (SSFP) sequences with parallel imaging (SENSE) for detection of coronary stenoses... - No effect of highly dosed nitric oxide donor molsidomine on the angiographic restenosis rate after percutaneous coronary angioplasty: a randomized, placebo controlled, double-blind trialJochen Wohrle
Department of Cardiology, University of Ulm, Ulm, Germany
Can J Cardiol 19:495-500. 2003..Because these effects are mainly dose dependent, NO-releasing drugs have to be applied at a high dose to have an effect on restenotic mechanisms... - Myocardial perfusion reserve assessed by T2-prepared steady-state free precession blood oxygen level-dependent magnetic resonance imaging in comparison to fractional flow reserveThomas Walcher
Department of Internal Medicine II, University of Ulm, Albert Einstein Allee 2, Ulm, Germany
Circ Cardiovasc Imaging 5:580-6. 2012..The aim of our study was to analyze the potential diagnostic accuracy of BOLD CMR in comparison to invasively measured FFR, which served as gold standard for a hemodynamic significant coronary lesion... - Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imagingVinzenz Hombach
Department of Internal Medicine II Cardiology, University of Ulm, Robert Koch Strasse 8, D 89081 Ulm, Germany
Eur Heart J 26:549-57. 2005..Because of its high spatial resolution and tissue contrast, magnetic resonance imaging (MRI) was used to assess cardiac structure and function in a large population of patients with acute myocardial infarction (AMI)... - Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenosesSinisa Markovic
Department of Internal Medicine II, University of Ulm, Albert Einstein Allee 23, Ulm, Germany
Cardiovasc Revasc Med 13:307-10. 2012..We evaluated the outcome of EES compared with PES for treatment of restenosis in bare-metal and drug-eluting stents (DES)... - Quantification of myocardial perfusion reserve at 1.5 and 3.0 Tesla: a comparison to fractional flow reservePeter Bernhardt
Department of Internal Medicine II, University of Ulm, Albert Einstein Allee 23, 89081 Ulm, Germany
Int J Cardiovasc Imaging 28:2049-56. 2012..76.9 %). Quantitative analysis of CMR myocardial perfusion reserve at 1.5 and 3 T is capable to detect hemodynamic significance of coronary artery stenoses. Diagnostic accuracy at 3 T is to be superior to 1.5 T... - Re-angioplasty of in-stent restenosis versus balloon restenoses--a matched pair comparisonJochen Wohrle
Department of Cardiology, University of Ulm, Robert Koch Strasse 8, 89081 Ulm, Germany
Int J Cardiol 93:257-62. 2004.... - Characterization of patients with acute chest pain using cardiac magnetic resonance imagingVinzenz Hombach
Department of Internal Medicine II, University of Ulm, Ulm, Germany
Clin Res Cardiol 97:760-7. 2008.... - Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathyVinzenz Hombach
Clinic of Internal Medicine II, University Hospital Ulm, Albert Einstein Allee 23, Ulm 89081, Germany
Eur Heart J 30:2011-8. 2009..We assessed the prognostic value of cardiac magnetic resonance (CMR) parameters in addition to conventional clinical and electrocardiographic characteristics... - Angiographic results of a Tacrolimus-eluting stent in acute coronary syndrome lesionsAngelika Rinker
Department of Internal Medicine II, University of Ulm, Albert Einstein Allee 23, 89081 Ulm, Germany
Clin Res Cardiol 98:89-93. 2009.... - Is contrast-enhanced cardiac magnetic resonance imaging at 3 T superior to 1.5 T for detection of coronary artery disease?Thomas Walcher
Department of Internal Medicine II, University of Ulm, Albert Einstein Allee 23, 89081, Ulm, Germany
Int J Cardiovasc Imaging 29:355-61. 2013..3 vs. 88.9 %). This study showed that CMR at 3 T in a routine clinical setting is superior to 1.5 T in detection of significant CAD. 3 T might become the preferred CMR field strength for evaluation of CAD in clinical practice... - Intracoronary application of abciximab in patients with ST-elevation myocardial infarctionJochen Wohrle
Department of Internal Medicine II, University of Ulm, Ulm, Germany
EuroIntervention 3:465-9. 2008..02-7.44; p<0.0001) and female gender (OR 2.05; 95%-CI 1.15-3.65, p=0.014). Conclusions: The intracoronary administration of the abciximab bolus during PCI in STEMI patients is safe and associated with a low rate of MACE at 30 days... - Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trialIngo Eitel
Heart Center, Department of Internal Medicine, Cardiology, University of Leipzig, Leipzig, Germany
J Am Coll Cardiol 61:1447-54. 2013.... - Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virusGeorg Härter
University Hospital Ulm, Dept of Clinical Infectious Diseases and Clinical immunology, Comprehensive Infectious Diseases Center Ulm and Clinic of Internal Medicine III, Albert Einstein Allee 23, 89081 Ulm, Germany
Clin Infect Dis 50:1249-51. 2010..Zanamivir given intravenously may be a therapeutic option in patients with critical illness and mechanical ventilation...